Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-03-20
2007-03-20
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S222000
Reexamination Certificate
active
10942916
ABSTRACT:
The present invention relates to a compound of the formula [I]:wherein R1is lower alkyl or hydroxy(lower)alkyl, andR2is hydrogen or amino protecting group, orR1and R2are bonded together and form lower alkylene;R is -A-R6wherein A is bond, —NHCO—(CH2CO)n—, lower alkylene, —NH—CO—CO— or the like, andR6iswherein R7, R8, R9and R10are independently amino, guanidino, amidino or the like;R4is carboxy or protected carboxy; andR5is amino or protected amino, or a pharmaceutically acceptable salt thereof, a process for preparing a compound of the formula [I], and a pharmaceutical composition comprising a compound of the formula [I] in admixture with a pharmaceutically acceptable carrier.
REFERENCES:
patent: 4927818 (1990-05-01), Takaya et al.
patent: 4952578 (1990-08-01), Sakane et al.
patent: 5109130 (1992-04-01), Sakane et al.
patent: 5173485 (1992-12-01), Sakane et al.
patent: 5187160 (1993-02-01), Sakane et al.
patent: 5194432 (1993-03-01), Takaya et al.
patent: 5210080 (1993-05-01), Takaya et al.
patent: 5215982 (1993-06-01), Sakane et al.
patent: 5302712 (1994-04-01), Sakane et al.
patent: 5663163 (1997-09-01), Takaya et al.
patent: 2004/0132994 (2004-07-01), Ohki et al.
patent: 2004/0248875 (2004-12-01), Ohki et al.
patent: 2005/0004094 (2005-01-01), Yamanaka et al.
patent: 0 047 977 (1982-03-01), None
patent: 0 062 321 (1982-10-01), None
patent: 0 771 803 (1997-05-01), None
patent: 1 134 222 (2001-09-01), None
patent: WO 97/41128 (1997-11-01), None
patent: WO 02/090364 (2002-11-01), None
patent: WO 2004/039814 (2004-05-01), None
Raymond F. Brown, et al., “Synthesis and Biological Evaluation of a Series of Parenteral 3'-Quaternary Ammonium Cephalosporins”, Journal of Medicinal Chemistry, vol. 33, XP-001084083, 1990, pp. 2114-2121.
Kenji Sakagami, et al., “Synthetic Cephalosporins. VI. Synthesis and Antibacterial Activity of 7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetamido]-3-(3-hydroxy-4-pyridon-1-yl)methyl-3-cephem-4-carboxylic Acid and Related Compounds”, Chem. Pharm. Bull., vol. 38, No. 8, XP-001083825, 1990, pp. 2271-2273.
Derwent Publications, AN 1992-387716, XP-002267713, JP 04-288086, Oct. 13, 1992.
Inoue Satoshi
Itoh Kenji
Kawabata Kohji
Misumi Keiji
Murano Kenji
Astellas Pharma Inc.
Berch Mark L.
Wakunaga Pharmaceutical Co., Ltd.
LandOfFree
Cephem compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cephem compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cephem compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3789887